Everest Clinical Research Enables Faster and Higher Quality Data Insights for Trial Sponsors with Medidata Clinical Data Studio
Everest expands its 13-year Medidata partnership with the addition of its AI-embedded solution
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that Everest Clinical Research, a global full-service contract research organization (CRO), is expanding its partnership with Medidata by adopting Medidata Clinical Data Studio.
As an integral solution of the Medidata Data Experience, Clinical Data Studio, will help Everest streamline the management, standardization, and analysis of study data in real-time, resulting in accelerated data collection and enhanced data quality. This will enable robust data visualization capabilities for Everest’s clients and also support back-office efficiency and more seamless delivery across various therapeutic areas. As a result, Everest will deliver more actionable insights faster and foster more confident decision-making for sponsors, ultimately speeding the production of new medicines for patients.
“Everest is built on a foundation of data excellence, high quality execution, and operational rigor,” said Jin Dai, CEO, Everest Clinical Research. “Adopting Clinical Data Studio further empowers us to provide data-driven insights across complex global trials. This continued work with Medidata underscores our shared commitment to innovation and precision, allowing our sponsors to receive improved real-time transparency into trends and issues to better control and steer clinical trials for successful completion.”
“Powered by embedded AI, Clinical Data Studio is transforming the landscape of clinical data science and helping Everest Clinical Research boost productivity, shorten timelines, and strengthen its industry-leading standards of quality,” said Wayne Walker, senior vice president, Data Experience, Medidata. “Through this innovative technology, we’re equipping Everest and its clients with the tools to gain deeper insights and speed up the global development of vital new treatments for patients everywhere.”
The expanded relationship builds upon Everest’s successful utilization of Medidata eCOA and Medidata Rave EDC, available on the Medidata Platform, as well as the CRO’s recent addition of Medidata Intelligent Trials.
Contact:
Medidata PR
Analyst Relations